Ocular adverse effects of common psychotropic agents: a review.
Richa S, Yazbek JC.
CNS Drugs. 2010 Jun;24(6):501-26. doi: 10.2165/11533180-000000000-00000.
Bietti Crystalline Dystrophy.
Vargas M, Mitchell A, Yang P, Weleber R.
2012 Apr 12 [updated 2019 Feb 7]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
Exfoliation syndrome.
Ritch R, Schlötzer-Schrehardt U.
Surv Ophthalmol. 2001 Jan-Feb;45(4):265-315. doi: 10.1016/s0039-6257(00)00196-x.
Fuchs endothelial corneal dystrophy and corneal endothelial diseases: East meets West.
Soh YQ, Kocaba V, Pinto M, Mehta JS.
Eye (Lond). 2020 Mar;34(3):427-441. doi: 10.1038/s41433-019-0497-9. Epub 2019 Jul 2.
Cone rod dystrophies.
Hamel CP.
Orphanet J Rare Dis. 2007 Feb 1;2:7. doi: 10.1186/1750-1172-2-7.
Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
Huff LS, Prado R, Pederson JF, Dunnick CA, Lucas LM.
Cutis. 2014 May;93(5):247-50.
Heterochromia.
Lui F, Stokkermans TJ.
2023 Jun 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
[Pigment Dispersion Syndrome].
Nobl M, Mackert M.
Klin Monbl Augenheilkd. 2021 Apr 19. doi: 10.1055/a-1472-0471. Online ahead of print.
Unilateral Congenital Lenticular Pigmentation.
Al-Najmi Y, Alsaggaf A, Abdalla Elsayed MEA, Albeedh M.
Case Rep Ophthalmol. 2023 Nov 29;14(1):660-664. doi: 10.1159/000534927. eCollection 2023 Jan-Dec.
SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY.
GREINER AC, BERRY K.
Can Med Assoc J. 1964 Mar 14;90(11):663-5.
